Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
item | value |
Packaging | Drum, Vacuum Packed |
Place of Origin | China;Shaanxi |
Grade | Food and Pharmaceutical Grade |
MOQ | 10g |
CAS | 1613220-15-7 |
Sample | Avaliable |
Shelf Life | 2 Years |
Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.
The drug is approved by the US FDA for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.
AZD9291 | Lapatinib ditosylate | Lapatinib | Gefitinib |
Niraparib | Imatinib mesylate | Imatinib | LOXO 101 |
Ibrutinib | Cabozantinib Malate | baricitinib | Erlotinib Hydrochloride |
a. Customs clearance
1) By Express:
Normally there is no specical need for the recipient to clear the customs. If the customs has an objection,our rich experienced and peofessional group will help you clear the customs.
2) By Air and by Sea:
Our company will cooperate with the recipient to provide relevant file and information in the customs clearance procedure.
b. Payment
T/T,Wester Union,MoneyGram,****** Trade Assurance,L/C ,Bank transfer etc.